MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Consolidator ... Mass Market Scale-up, Global Reach, Public Capital
Consolidators: BioPharmaceuticals
AstraZeneca PLC (NASDAQ:AZN)*
Attachments
AstraZeneca - Research-Based BioPharmaceutical Company
Parents
*2012: Pharmaceutical: Market Leaders
*2020: Who's Ahead In Finding A COVID-19 Vaccine?
*2025: Here are the 50 largest bioscience employers in Greater Washington
*CIMIT (Harvard/MIT) :Industrial Liaison Program (ILP)
*Consolidators: Biotechnology
*Consolidators: Diabetes and Kidney Health Companies
*Industry: United Kingdom - UK (England, Scotland, Wales, Northern Ireland)
2010: How To Keep Academic/Big Pharma Alliances from Going off the Rails
2014: Cepheid Partners with AstraZeneca, GSK, Cubist to Develop Rapid Dx for Drug-Resistant Pathogens
2014: Industry, Academic Collaborations Fuel the Innovation Engine
2014: Who's The Best In Drug Research? 22 Companies Ranked
2018: The top 15 pharma companies by 2017 revenue
2020: Coronavirus Infects Wall Street — Can Biotech Stocks Ride To The Rescue?_www.investors.com
2020: UPDATED: White House names finalists for Operation Warp Speed
2021: The top 20 pharma companies by 2020 revenue
2021: Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020/2021
2022: The top 10 vaccine companies worldwide
2022: The top 20 pharma companies by 2021 revenue
2023: 20 Most Valuable Healthcare Companies in the World
2023: Ranking The Top 10 Pharmaceuticals By Pipeline_seekingalpha.com
2023: Top 10 pharma R&D budgets in 2022
2024: 15 Most Profitable Biotechnology Companies in the World
2024: Drugmakers bet billions that targeted radiation could become the next cancer breakthroughwww.cnbc.com
2025: As Alphabet nears $4T, here are top 10 healthcare stocks by market cap (XLV:NYSEARCA)
2025: The top 10 pharma R&D budgets for 2024
2025: The top 20 pharma companies by 2024 revenue
2026: FDA launches ‘real-time’ clinical trials
2026: MFN Program Grows to 26 Drugmakers as Nine More Commit to $19.6B in US Manufacturing
2026: The top 10 pharma R&D budgets of 2025
Companies: Acquiring (M&A)
Consolidators: BioPharmaceuticals
Consolidators: Cancer/Oncology Diagnostics & Treatment Companies
Consolidators: Nanotechnology, Nanomedicine & MEMS
Consolidators: Personalized Medicine
Consolidators: Pulmonology, Respiratory
Consolidators: Vaccine Development
Investors AB of Sweden
Children
*Key People: AstraZeneca
Cambridge, England, United Kingdom
Finance & Acquisition: AstraZeneca
Founded 1999
Organization & Developments: AstraZeneca
Jumps
*Architects / Consolidators: Infectious Disease_Coronavirus (Covid-19)
*Pioneers: Cardiology & Cardiovascular (Vulnerable Plaque)
2021: Mila (the Quebec Artificial Intelligence Institute)
Absci Corporation (NASDAQ: ABSI)*
Adherium Ltd
AIM ImmunoTech Inc. (AIM)*
Array BioPharma (NASDAQ: ARRY)
Barinthus Biotherapeutics (NASDAQ: BRNS), formerly, Vaccitech plc (NASDAQ: VACC)*
BenevolentAI*
Bicycle Therapeutics plc (NASDAQ: BCYC)*
BIND Therapeutics (NASDAQ: BIND)
C2i Genomics, Inc.
Cancer Research UK
Corvidia Therapeutics
CSPC Pharmaceutical Group Limited
Dynavax Technologies Corporation (NASDAQ:DVAX)*
Evinova
FibroGen, Inc (NASDAQ: FGEN)*
Guardant Health Inc. (NASDAQ:GH)*
Hutchison China MediTech, or Chi-Med
Illumina, Inc. (NASDAQ: ILMN)
Immunocore Holdings plc (NASDAQ: IMCR)*
Innate Pharma SA (NASDAQ: IPHA)*
Inovio Pharmaceuticals, Inc. (NASDAQ: INO)*
Mereo BioPharma Group plc (NASDAQ: MREO)
Nabla Bio, Inc.*
Nanoform
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS)
Pozen
Qure.ai Technologies Private limited
Regulus Therapeutics Inc. (NASDAQ: RGLS)*
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL)*
Sage Bionetworks
Serum Institute of India
Shenzhen University
SixPeaks Bio
Targacept (NASDAQ:TRGT)
University of Oxford
University of Pennsylvania
Viela Bio (VIE)
X-Chem